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Autoimmune pancreatitis as chronic inflammation of the pancreas due to an autoim-
mune mechanism is a rare type of pancreatitis. A 14 years old girl presented with mul-
tiple episodes of abdominal pain, nausea with elevation of amylase and lipase sus-
picions of acute recurrent pancreatitis since 3 years of age. After through evaluation 
about secondary causes of recurrent and familial pancreatitis finally she responded 
to corticosteroid treatment. Although very rare but autoimmune processes should be 
considered in teenagers with recurrent pancreatitis.
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INTRODUCTION
Autoimmune pancreatitis (AIP) is a rare distinctive type of 
pancreatitis that defined as chronic inflammation of the pancre-
as due to an autoimmune mechanism; autoimmunity is respon-
sible for producing the pancreatic lesion [1, 2]. AIP diagnosis 
are mainly based on a combination of five cardinal features 
including pancreas histology and imaging findings, positive se-
rology, presence of other autoimmune or inflammatory organ 
diseases, and prompt response to corticosteroids [3].
AIP in adults is a well-known condition and classified into two 
subgroups. Type 1 is more common in elderly Asian males, in-
volves other organs and is associated with a raised immuno-
globulin G4 (IgG4). Type 2 has been described in population 
from Europe and North America, with a normal serum IgG4 
and is more commonly associated with the development of ul-
cerative colitis. 
There are limited published cases and case series  about AIP 
in children  and  pediatric gastroenterologists rely on the adult 
AIP guidelines or experience of other prior publish reports to 
diagnose and manage AIP in children [4, 5]. 
Review of literature about childhood AIP suggest that the clin-
ical presentation of AIP is different in children compared with 
adults, and that exclusive use of adult criteria may lead to un-
derdiagnoses of AIP in children and management and treatment 
such cases may need for specific strategy case by case.
Here we report a case of 14 years old girl who referred to us 
with history of recurrent pancreatitis that managed as AIP.
CASE PRESENTATION
A 14 years old girl presented to our medical center with history 
of multiple episodes of abdominal pain, nausea with elevation 
of amylase and lipase that resulted to admission to hospital and 
treat with suspicions of acute pancreatitis. First episode start-
ed in her third years of life. And approximate period time be-
tween each episode was at least six months. During this period 
of time, patient was asymptomatic and serum level of amylase 
and lipase were normal. 
She had history of febrile seizure that start in her first year of 
life and that has been controlled by phenobarbital. Also she has 
a maternal relatives’ history of ulcerative colitis, dermatitis and 
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 DISCUSSION
Diagnosis of AIP in children can be established based on the 
combination of clinical symptoms at presentation and imaging 
findings. Therefore, some investigators have suggested using a 
combination of laboratory testing, imaging, histological find-
ings, association to other autoimmune disease, and response to 
corticosteroid treatment to establish the diagnosis.
In the retrospective analysis of the literature involving 38 chil-
dren with AIP, abdominal pain was most common symptom 
following by obstructive jaundice and weight loss [6]. Nausea 
and vomiting, fatigue and abnormal stool were other less fre-
quents clinical symptoms patients. 
Although there is no specific imaging finding in AIP, but com-
bination of radiological finding with the clinical symptoms can 
be helpful in diagnosis of AIP. Transabdominal ultrasound scan 
(USS) is often the first available imaging modality. Focal and 
global pancreas enlargement are most common findings in USS 
respectively [6].Other USS findings includes bile duct dilation 
and liver fatty changes. Our findings in USS were non-homog-
enous pancreas with hypoechoic foci’s and dilation of pancre-
atic duct.
Magnetic resonance cholangiopancreatography (MRCP) find-
ing also included of focal and global enlargement that pre-
sented with hypointence areas on T1-weghted images. Other 
common findings are irregularities of the main pancreatic duct 
and a narrowed CBD (stricture or tapering). Main pancreatic 
duct irregularities and distal CBD narrowing are nonspecific 
findings and might also be seen in patients with CP or biliopan-
creatic diseases of any other etiology or even in primary scle-
rosing cholangitis type 1 [6, 7].
A capsule-like rim enhancement of the pancreas was infrequent 
in children but its occurrence appears to be pathognomonic for 
the disease [6]. A pancreatic head enlargement or nonencapsu-
lated mass lesions were other frequent findings. It should be 
note that lymphoma, pancreatoblastoma or solid pseudopapil-
lar epithelial neoplasms that are often encapsulated and express 
cystic and solid components should be ruled out after a focal 
pancreas enhancement.
Increased serum IgG4 is very suggestive of AIP in adults, but 
IgG4 serology and immunostaining is rarely positive in chil-
dren with AIP. This marker is of limited value as only 22% of 
the children had IgG4 levels above the upper limits of normal 
(ULN). In comparison, about 65% of adult AIP type 1 and 25% 
of adult AIP type 2 patients have elevated IgG4 levels. This 
suggests that children may more commonly follow the disease 
presentation of AIP type 2 or may have a distinct AIP pattern 
that may not necessarily fall into either category.
A diagnosis of AIP can be confirmed by the histopathological 
identification of pathognomonic and well-described features of 
an autoinflammatory process in the pancreas tissue specimen. 
Most common findings in AIP patients are a combination of 
lymphoplasmacytic infiltration, pancreatic fibrosis, and granu-
locyte infiltration of the pancreatic duct epithelium and lumen 
(also called granulocytic epithelial lesion). Frequent finding of 
granulocytic epithelial lesion in pediatric pancreas tissue spec-
imen would be consistent with type 2 AIP as per adult criteria. 
rheumatoid arthritis.
She was referred to our center for further investigations. She 
had ongoing epigastric pain and nausea and elevated amy-
lase and lipase serum level. Her total IgG were within normal 
range. All autoantibodies were in normal ranges and genetic 
evaluations about common mutation in familial pancreatitis 
were negative. 
Liver ultrasound scan on presentation showed dilated extrahe-
patic bile ducts and non- homogenous pancreas with hypere-
choic foci’s. Also there was dilation of pancreatic duct at the 
level of the pancreatic head and body.
MRCP confirmed marked intra-and extrahepatic cholangiopa-
thy with smooth inflammatory stricture of the distal bile duct 
within the pancreatic head and neck. There was rim-like en-
hancement around the uncinate process of the pancreas as well 
as smooth stricturing and dilatation of the pancreatic duct sug-
gestive of AIP as a potential etiology (Figure 1).
Endoscopic retrograde cholangiopancreatography (ERCP) was 
performed to assess patency of pancreaticobiliary system and 
ampullary endoscopic biopsies that revealed no positive find-
ings.
Based on clinical and paraclinical findings, AIP diagnosed. The 
patient was commenced on full dose of 40mg prednisolone OD 
(1 mg/kg/day) for two weeks followed by tapering down to 
5mg/day and then 2.5mg /day over three month, after this peri-
od, prednisolone was stopped. 
In post-treatment follow up the patient has been asymptomatic 
since then with no episode of pancreatitis and no complication 
of pancreatic insufficiency, such as diabetes, until now. 
A case report and literature reveiw of autoimmune pancreatitis
Figure 1. MRCP T2-weighted three-dimensional (3D) cholangiogram recon-
struction showing significant dilation and tortuosity of MPD, possibility of 
multiple small cystic structures around pancreatic duct, small filling defects 
within pancreatic duct, a hypointense capsule-like rim around it and Stricture 
of the distal CBD within the pancreatic head. (MRCP: Magnetic resonance 
cholangiopancreatography, MPD: main pancreatic duct, CBD: Common bile 
duct). Although most of these features are not specific for P-AIP, the presence 
of more than one should raise the suspicion for P-AIP.
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However, because of the increased clinical recognition of AIP 
as well as a growing familiarity with AIP-type imaging find-
ings, adult gastroenterologists often times waive a histopatho-
logical diagnosis and start a trial with corticosteroids that itself 
is used as a diagnostic criterion to confirm the diagnosis of AIP 
[3,4].
Although granulocytic epithelial lesion is more frequently 
found in the pancreas of children with AIP compared with 
adults. If adult AIP criteria were applied to the pediatric AIP 
population, children would most likely be classified as having 
type 2 AIP. However, as histology of pancreas biopsies in chil-
dren with AIP have not yet been validated in relation to the 
disease phenotype [3], we cannot at this point exclude the pos-
sibility that AIP in children may yet follow a distinct disease 
pattern.
In our patient, the diagnosis of AIP was based on the MRCP 
and ERCP imaging finding, although negative autoimmune an-
tibodies and normal levels of immunoglobulins especially IgG 
and subclass 4 were obtained. These results are similar to those 
in the patients presented by Toomey et al.[8] who diagnosed 
AIP based on the abdominal US and CT imaging features of 
a solid mass in the pancreatic body despite normal serum IgG 
and elevated CA19-9 levels and patient presented by Refaat et 
al. [9] who diagnosed AIP based on the MR and MRCP.
We agreed with Finkelberg et al. [10] who state that diagnosis 
may be made in the absence of diagnostic laboratory finding
A total of 27% of children and 10–20% of adults [5] diagnosed 
with AIP have concurrent immune/inflammatory diseases, es-
pecially ulcerative colitis. It remains to be elucidated whether 
the pancreas inflammation drives the intestinal inflammation 
in these cases or whether the intestinal inflammation spreads 
to the pancreas.
The therapeutic approach to AIP has significantly evolved over 
time. In the early days, surgery was undertaken to confirm the 
nature of a pancreatic mass and/or drain an obstructed bile 
duct. ERCP was used for CBD stenting in children with ob-
structive jaundice. 
The current standard treatment for AIP is corticosteroid ther-
apy [11]. The corticosteroid induction dose used in children 
(1–1.5 mg/kg/day) as captured in our study was higher than 
the recommended dose (0.6–1 mg/kg/day) in adults with AIP. 
Of the children, 92% including our patient clinically improved 
with corticosteroids. Interestingly, 17% of the AIP patients had 
disease resolution without any treatment. Although cortico-
steroid use seems beneficial in the short term in adults with 
AIP, it remains unclear whether it has an impact on the long-
term outcome of patients. In the absence of any comparative 
or outcome studies in children, we believe that a time-limited 
corticosteroid treatment courses to treat the acute symptoms of 
pancreatitis, which may also prevent long-term complications 
of pancreatic insufficiency, is justified. As in the one-year fol-
low up, our patient did not suffer from pancreatic insufficiency 
and complications such as diabetes and son on.
However, further studies are needed to determine whether the 
advantages of steroid therapy outbalance the potential side ef-
fects of this therapy, particularly in children. In this regard, it 
will be helpful to obtain control imaging about 3 months after 
starting corticosteroids to evaluate for normalization of the pan-
creatic imaging findings, confirming the diagnosis of AIP.
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